HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $201,000 | -1.0% | 5,000 | 0.0% | 0.04% | -11.9% |
| Q3 2021 | $203,000 | -10.6% | 5,000 | 0.0% | 0.04% | -8.7% |
| Q2 2021 | $227,000 | -45.6% | 5,000 | -50.0% | 0.05% | -51.1% |
| Q1 2021 | $417,000 | -34.9% | 10,000 | -33.3% | 0.09% | -37.3% |
| Q4 2020 | $641,000 | +43.4% | 15,000 | -11.8% | 0.15% | +29.3% |
| Q3 2020 | $447,000 | -2.0% | 17,000 | 0.0% | 0.12% | -13.4% |
| Q2 2020 | $456,000 | +15.2% | 17,000 | -22.7% | 0.13% | -21.6% |
| Q1 2020 | $396,000 | – | 22,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |